CLPT Q1 2019 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2M+52.3% YoY

Gross Profit

$2M64.1% margin

Operating Income

-$972,249-39.3% margin

Net Income

-$1M-49.4% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

-$609,463

Free Cash Flow

-$609,463

Stock-Based Comp.

$152,586

Balance Sheet

Total Assets

$8M

Total Liabilities

$7M

Stockholders' Equity

$442,619

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+52.3%
Gross Profit	$2M	$1M	+53.3%
Operating Income	-$972,249	-$1M	+31.9%
Net Income	-$1M	-$2M	+25.6%

Revenue Segments

Product Revenues

$2M44%

Functional Neurology

$2M32%

Service and Other Revenues

$308,5646%

Biologics And Drug Delivery

$284,9106%

Capital Equipment

$274,3996%

Capital Equipment and Other

$211,2024%

BiologicsAndDrugDelivery1Member

$97,3622%